Male Infertility Global Market Opportunities And Strategies To 2034

Male Infertility Market 2025 - By Treatment Type (Medication, Surgery, Assisted Reproductive Technology) , By Test Type (Sperm Agglutination, Deoxyribonucleic Acid Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, Other Test Types) , By End-User (Hospitals And Clinics, Fertility Centers, Research Institutes, Other End-Users) ) ), And By Region, Opportunities And Strategies – Global Forecast To 2035

Male Infertility Global Market Opportunities And Strategies To 2034

Report Price : $4490.00 $3367.00 | Pages : 332 | Published : September 2025 | Delivery Time: Immediately Info icon | Format : pdf icon

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Regional Data
Male Infertility Global Market Opportunities And Strategies To 2034
Description Table Of Contents Tables & Figures

Market Insights

Related Reports

Male Infertility Market Definition

Male infertility is a medical condition in which a man has a reduced ability or inability to cause pregnancy in a fertile female partner. It is commonly caused by issues such as low sperm count, poor sperm motility, abnormal sperm shape, hormonal imbalances, genetic defects, or blockages in the reproductive tract. The primary purpose of addressing male infertility is to identify and treat the underlying causes to improve the chances of natural conception or assist with reproduction through medical interventions.

The male infertility market consists of sales, by entities (organizations, sole traders and partnerships), of male infertility that are used by individuals or couples seeking to conceive, its treatment is sought whenever conception challenges arise, which can be at any age but most commonly in men 30–50 years old.

Male Infertility Global Market Opportunities And Strategies To 2034 Market Size and growth rate 2025 to 2029: Graph

Male Infertility Market Size

The global male infertility market reached a value of nearly $4,103.03 million in 2024, having grown at a compound annual growth rate (CAGR) of 4.19% since 2019. The market is expected to grow from $4,103.03 million in 2024 to $5,427.76 million in 2029 at a rate of 5.76%. The market is then expected to grow at a CAGR of 5.55% from 2029 and reach $7,109.72 million in 2034.

Growth in the historic period resulted from the impact of delayed parenthood, rise in medical tourism, rise in environmental and occupational hazards and rising investments in R&D and fertility biotech. Factors that negatively affected growth in the historic period were high cost of treatment and limited insurance coverage.

Going forward, the growth in fertility clinics and reproductive health services, government initiatives, increasing stress levels and increasing incidence of lifestyle disorders will drive the growth. Factor that could hinder the growth of the male infertility market in the future include regulatory and ethical issues, social stigma and lack of awareness and impact of trade war and tariff.  

Male Infertility Market Drivers

The key drivers of the male infertility market include:

Growth In Fertility Clinics And Reproductive Health Services

During forecast period, the growth in fertility clinics and reproductive health services are expected to propel the growth of the male infertility market. As awareness of male reproductive health issues increases, more individuals and couples are seeking specialized care, leading to a higher demand for diagnostic and treatment options. Fertility clinics are broadening their service offerings to include advanced male infertility solutions, such as semen analysis, hormonal testing, and sperm enhancement technologies. This growing infrastructure, combined with improved access to care and greater societal acceptance of male infertility as a medical condition, is expected to fuel market development and create new opportunities for healthcare providers and diagnostic companies. Therefore, the growth in fertility clinics and reproductive health services will drive the growth of the male infertility market.  The growth in fertility clinics and reproductive health services growth contribution during the forecast period in 2024 is 1.50%.

Male Infertility Market Restraints

The key restraints on the male infertility market include:

Social Stigma And Lack of Awareness

During forecast period, social stigma and lack of awareness is expected to hinder the growth of the male infertility market. Many men feel embarrassment or shame when addressing fertility issues, which often leads to delays in seeking medical evaluation or treatment. Additionally, limited public education and discussion around male infertility contribute to underdiagnosis and underutilization of available services and technologies. This cultural barrier not only reduces patient engagement but also affects market penetration for companies offering male-focused fertility solutions. Addressing these challenges through awareness campaigns and education is crucial for unlocking the market’s full growth potential. Therefore, social stigma and lack of awareness may hinder the growth of the male infertility market.  Growth affected by social stigma and lack of awareness during the forecast period in 2024 is -2.11%.

Male Infertility Market Trends

Major trends shaping the male infertility market include:

Strategic Investments Driving Innovation In Reproductive Health Solutions

Major companies operating in the male infertility market are focusing on strategic investment, to accelerate the development of novel diagnostic tools and treatments, expand their technological capabilities, and capture a larger share of the growing fertility care market. A strategic investment is an investment made by a company or organization with the primary goal of gaining long-term business benefits beyond just financial returns. For instance, in October 2024, Paterna BioSciences Inc., a US-based biotechnology company, has raised $6 million in an oversubscribed seed round led. The funding accelerates development of its pioneering in vitro spermatogenesis (IVS) technology to address male infertility, responsible for nearly 50% of failed in vitro spermatogenesis (IVS) cycles. Paterna aims to bring its fertility solution to early-phase trials in 2025, advancing reproductive care with innovative science based on a decade of research. The funding will accelerate preclinical development, infrastructure, and team growth, with early-phase studies expected in 2025.

Advancing Male Infertility Diagnosis Through At-Home Fertility Test

Companies operating in the male infertility market are focusing on developing at-home fertility test for gaining competitive advantage. The at-home fertility test is designed to provide an easier and faster process to traditional fertility testing, a cheaper alternative to specialist appointments and to also alleviate pressure on the National Health Service (NHS). For instance, in June 2023, Newfoundland, a UK-based company specializing in the development and distribution of diagnostic health tests launched the fastest and most affordable at-home fertility test. The new test, which is available over the counter, gives fertility results in just five minutes and boasts 98.2 per cent accuracy. The new at-home Male Fertility test will give men the opportunity to understand more about their fertility and seek the right medical advice if needed.

Opportunities And Recommendations In The Male Infertility Market

Opportunities – The top opportunities in the male infertility markets segmented by treatment type will arise in the assisted reproductive technology segment, which will gain $695.16 million of global annual sales by 2029. The top opportunities in the male infertility markets segmented by test type will arise in the deoxyribonucleic acid fragmentation technique segment, which will gain $409.37 million of global annual sales by 2029. The top opportunities in the male infertility markets segmented by end-user will arise in the fertility centers segment, which will gain $643.79 million of global annual sales by 2029. The male infertility market size will gain the most in the USA at $300.86 million.

Recommendations- To take advantage of the opportunities, The Business Research Company recommends the male infertility companies to focus on strategic investment to advance diagnostic and therapeutic innovation, focus on at-home fertility testing to expand access and drive differentiation, focus on assisted reproductive technology to capture high-growth market share, focus on oxidative stress analysis to maximize growth potential, expand in emerging markets, continue to focus on developed markets, provide competitively priced offerings, continue to use B2B promotions, focus on strategic partnerships to broaden access and support early male fertility evaluation and focus on fertility centers to accelerate market penetration.

chesta image

Book your 30 minutes free consultation with our research experts

Contact Us

Male Infertility Market Segmentation

The male infertility market is segmented by treatment type, by test type and by end user type.



By Treatment –


The male infertility market is segmented by treatment into:

    • a)Medication

    • b) Surgery

    • c)Assisted Reproductive Technology (ART)

The assisted reproductive technology (ART) market was the largest segment of the male infertility market segmented by treatment type, accounting for 46.45% or $1,905.69 million of the total in 2024. Going forward, the assisted reproductive technology (ART)segment is expected to be the fastest growing segment in the male infertility market segmented by treatment type, at a CAGR of 6.42% during 2024-2029.



By Component –


The male infertility market is segmented by component into:

    • a) Sperm Agglutination

    • b)Deoxyribonucleic Acid (DNA) Fragmentation Technique

    • c)Oxidative Stress Analysis

    • d)Computer Assisted Semen Analysis

    • e)Sperm Penetration Assay

    • f)Other Test Types

The deoxyribonucleic acid (DNA) fragmentation technique market was the largest segment of the male infertility market segmented by test type, accounting for 22.84% or $937.07 million of the total in 2024. Going forward, the oxidative stress analysis segment is expected to be the fastest growing segment in the male infertility market segmented by test type, at a CAGR of 8.42% during 2024-2029.



By End User –


The male infertility market is segmented by end user into:

  1. a)Hospitals And Clinics

  2. b)Fertility Centers

  3. c)Research Institutes

  4. d)Other End-Users

The fertility centers market was the largest segment of the male infertility market segmented by end-user, accounting for 44.17% or $1,812.44 million of the total in 2024. Going forward, the fertility centers segment is expected to be the fastest growing segment in the male infertility market segmented by end-user, at a CAGR of 6.27% during 2024-2029.



By Geography - The male infertility market is segmented by geography into:

      oAsia Pacific

      • •China

      • •India

      • •Japan

      • •Australia

      • •Indonesia

      • •South Korea

      oNorth America

      • •USA

      • •Canada

      oSouth America

      • •Brazil

      oWestern Europe

      • •France

      • •Germany

      • •UK

      • •Italy

      • •Spain

      oEastern Europe

      • •Russia

      oMiddle East

      oAfrica

North America was the largest region in the male infertility market, accounting for 29.27% or $1,201.06 million of the total in 2024. It was followed by Western Europe, Asia Pacific and then the other regions. Going forward, the fastest-growing regions in the male infertility market will be Asia Pacific and South America where growth will be at CAGRs of 6.55% and 6.18% respectively. These will be followed by North America and Eastern Europe where the markets are expected to grow at CAGRs of 5.74% and 5.69% respectively.

Male Infertility Market Competitive Landscape

Major Competitors are:

  • Bayer AG

  • Merck KGaA / Merck Serono

  • Zydus Lifesciences

  • Intas Pharmaceuticals Ltd

  • CooperSurgical Inc.

    • Other Competitors Include:

  • Vitrolife Group (Vitrolife AB)

  • CinnaGen Co.

  • Kindbody Inc.

  • Aytu BioScience Inc.

  • Fortis Healthcare Ltd.

  • Sun Pharmaceutical Industries Ltd

  • Monash IVF

  • City Fertility

  • Genea Fertility

  • Queensland Fertility Group

  • Nova IVF Fertility

  • Cloudnine Fertility

  • Bloom IVF

  • Cipla Limited

  • Ferring Pharmaceuticals

  • NYU Langone Hospitals

  • Max Healthcare Institute Limited

  • Zydus Hospital

  • Indira IVF

  • Jinxin Fertility Group Ltd

  • Merck Ltd. Korea

  • IVFAustralia

  • NeoGenix Biosciences

  • Mankind Pharma

  • Morula IVF Indonesia

  • Guangzhou KingMed Diagnostics Group Co., Ltd.

  • Beijing Perfect Family Hospital

  • Kindstar Globalgene Technology, Inc.

  • Bloomage BioTechnology Corporation Limited

  • Shenzhen GeneoDx Biotechnology Co., Ltd.

  • Keio University Hospital

  • Sanno Hospital (Tokyo)

  • Oak Clinic Group (Osaka, Tokyo, etc.)

  • Sysmex Corporation

  • Nipro Corporation

  • Aska Pharmaceutical Co., Ltd.

  • Shionogi & Company, Limited

  • CHA Fertility Center (CHA Medical Group)

  • Maria Fertility Hospital

  • Seoul Samsung Medical Center

  • GeneMatrix

  • MediFuture Inc.

  • Bioneer Corporation

  • Novartis AG

  • Andrology Solutions

  • Halotech DNA

  • Bayer Pharma AG

  • Endo International plc

  • Sanofi S.A.

  • Esco Medical

  • Genea Biomedx

  • INVO Bioscience

  • Nidacon

  • GlaxoSmithKline plc

  • Ovom Care

  • Clinical Hospital of Barcelona

  • Spermosens AB

  • Sanatorium Helios

  • Gennet Clinics

  • Reprofit International

  • ISCARE IVF Clinic

  • Invicta Fertility Clinics

  • Gyncentrum Fertility Clinic

  • Klinika Bocian

  • Novum Fertility Clinic

  • Gynera Fertility Center

  • Clinica Nativia

  • AltraVita IVF Clinic

  • GMS Clinic

  • Reproductive Medicine Associates

  • Paterna BioSciences

  • Posterity Health

  • EMD Serono

  • Cadila Healthcare Ltd.

  • SCSA Diagnostics, Inc.

  • Cryogene

  • AIVF

  • Huntington Medicina Reprodutiva

  • Androfert

  • Fertility Buenos Aires

  • Cegyr

  • Procrearte

  • Inser Bogotá

  • IVF Colombia

  • Reprotec

  • Clínica Monteblanco

  • IVI Santiago

  • Red Salud UC Christus

  • Instituto Nacional de Fertilidad (INFERTIL)

  • Clínica Procrear

  • Ecuagénesis

  • Clínica Gyneman

  • Centro Médico Docente La Trinidad

  • IVF & Andrology Centers (Mohammed bin Rashid University Hospital)

  • Fakih IVF Fertility Center

  • International Medical Center (IMC) Jeddah – Andrology & Infertility Clinic

  • IVI Middle East Fertility Clinic

  • Conceive Gynecology & Fertility Hospital

  • ART Fertility Clinics

  • Al Ahli Hospital – Fertility Center

  • Badr Al Samaa Fertility Center

  • Avicenna Fertility Center

  • The Egyptian IVF Center

  • Dar Al Teb Infertility & IVF Center

  • Aevitas Fertility Clinic

  • Vitalab Fertility Clinic

  • Mediclinic Southern Africa

  • Cape Fertility Clinic

  • Nordica Fertility Centre

  • Bridge Clinic Nigeria

  • Nairobi IVF Centre

  • Aga Khan University Hospital Fertility Clinic
    • Author : Abdul Wasay

      Table Of Contents

      1Executive Summary

      1.1Male Infertility – Market Attractiveness And Macro Economic Landscape

      2Table Of Contents

      3List Of Tables

      4List Of Figures

      5Report Structure

      6Market Characteristics

      6.1General Market Definition

      6.2Summary

      6.3Male Infertility Market Definition And Segmentations

      6.4Market Segmentation By Treatment Type

      6.4.1Medication

      6.4.2Surgery

      6.4.3Assisted Reproductive Technology (ART)

      6.5Market Segmentation By Test Type

      6.5.1Sperm Agglutination

      6.5.2Deoxyribonucleic Acid (DNA) Fragmentation Technique

      6.5.3Oxidative Stress Analysis

      6.5.4Computer Assisted Semen Analysis (CASA)

      6.5.5Sperm Penetration Assay

      6.5.6Other Test Types

      6.6Market Segmentation By End-User

      6.6.1Hospitals and Clinics

      6.6.2Fertility Centers

      6.6.3Research Institutes

      6.6.4Other End-Users

      7Major Market Trends

      7.1Strategic Investments Driving Innovation In Reproductive Health Solutions

      7.2Advancing Male Infertility Diagnosis Through At-Home Fertility Test

      7.3Empowering Male Reproductive Health Through At-Home Diagnostic Innovation

      7.4Strengthening Fertility Care Through Collaborative Digital Health Initiatives

      8Global Male Infertility Growth Analysis And Strategic Analysis Framework

      8.1Global Male Infertility PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)

      8.1.1Political

      8.1.2Economic

      8.1.3Social

      8.1.4Technological

      8.1.5Environmental

      8.1.6Legal

      8.2End User Analysis (B2B)

      8.2.1Hospitals And Clinics

      8.2.2Fertility Centers

      8.2.3Research Institutes

      8.2.4Other End-Users

      8.3Global Male Infertility Market Growth Rate Analysis

      8.4Historic Market Growth, 2019 – 2024, Value ($ Million)

      8.4.1Market Drivers 2019 – 2024

      8.4.2Market Restraints 2019 – 2024

      8.5Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)

      8.6Forecast Growth Contributors/Factors

      8.6.1Quantitative Growth Contributors

      8.6.2Drivers

      8.6.3Restraints

      8.7Global Male Infertility Total Addressable Market (TAM)

      9Global Male Infertility Market Segmentation

      9.1Global Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.2Global Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.3Global Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.4Global Male Infertility Market, Sub-Segmentation Of Medication, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.5Global Male Infertility Market, Sub-Segmentation Of Surgery, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      9.6Global Male Infertility Market, Sub-Segmentation Of Assisted Reproductive Technology (ART), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10Male Infertility Market, Regional and Country Analysis

      10.1Global Male Infertility Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      10.2Global Male Infertility Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11Asia-Pacific Market

      11.1Summary

      11.2Market Overview

      11.2.1Region Information

      11.2.2Market Information

      11.2.3Background Information

      11.2.4Government Initiatives

      11.2.5Regulations

      11.2.6Regulatory Bodies

      11.2.7Major Associations

      11.2.8Taxes Levied

      11.2.9Corporate Tax Structure

      11.2.10Investments

      11.2.11Major Companies

      11.3Asia-Pacific Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.4Asia-Pacific Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.5Asia-Pacific Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.6China Market

      11.7Summary

      11.8Market Overview

      11.8.1Country Information

      11.8.2Market Information

      11.8.3Background Information

      11.8.4Government Initiatives

      11.8.5Regulations

      11.8.6Regulatory Bodies

      11.8.7Major Associations

      11.8.8Taxes Levied

      11.8.9Corporate Tax Structure

      11.8.10Major Companies

      11.9China Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.10China Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.11China Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.12India Market

      11.13India Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.14India Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.15India Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.16Japan Market

      11.17Summary

      11.18Market Overview

      11.18.1Country Information

      11.18.2Market Information

      11.18.3Background Information

      11.18.4Government Initiatives

      11.18.5Regulations

      11.18.6Regulatory Bodies

      11.18.7Major Associations

      11.18.8Taxes Levied

      11.18.9Corporate Tax Structure

      11.18.10Investments

      11.18.11Major Companies

      11.19Japan Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.20Japan Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.21Japan Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.22Australia Market

      11.23Australia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.24Australia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.25Australia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.26Indonesia Market

      11.27Indonesia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.28Indonesia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.29Indonesia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.30South Korea Market

      11.31Summary

      11.32Market Overview

      11.32.1Country Information

      11.32.2Market Information

      11.32.3Background Information

      11.32.4Government Initiatives

      11.32.5Regulations

      11.32.6Regulatory Bodies

      11.32.7Major Associations

      11.32.8Taxes Levied

      11.32.9Corporate Tax Structure

      11.32.10Investments

      11.32.11Major Companies

      11.33South Korea Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.34South Korea Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      11.35South Korea Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12Western Europe Market

      12.1Summary

      12.2Market Overview

      12.2.1Region Information

      12.2.2Market Information

      12.2.3Background Information

      12.2.4Government Initiatives

      12.2.5Regulations

      12.2.6Regulatory Bodies

      12.2.7Major Associations

      12.2.8Taxes Levied

      12.2.9Corporate tax structure

      12.2.10Investments

      12.2.11Major Companies

      12.3Western Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.4Western Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.5Western Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.6Western Europe Male Infertility Market: Country Analysis

      12.7UK Market

      12.8UK Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.9UK Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.10UK Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.11Germany Market

      12.12Germany Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.13Germany Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.14Germany Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.15France Market

      12.16France Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.17France Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.18France Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.19Italy Market

      12.20Italy Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.21Italy Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.22Italy Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.23Spain Market

      12.24Spain Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.25Spain Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      12.26Spain Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13Eastern Europe Market

      13.1Summary

      13.2Market Overview

      13.2.1Region Information

      13.2.2Market Information

      13.2.3Background Information

      13.2.4Government Initiatives

      13.2.5Regulations

      13.2.6Regulatory Bodies

      13.2.7Major Associations

      13.2.8Taxes Levied

      13.2.9Corporate Tax Structure

      13.2.10Major companies

      13.3Eastern Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.4Eastern Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.5Eastern Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.6Russia Market

      13.7Russia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.8Russia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      13.9Russia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14North America Market

      14.1Summary

      14.2Market Overview

      14.2.1Region Information

      14.2.2Market Information

      14.2.3Background Information

      14.2.4Government Initiatives

      14.2.5Regulations

      14.2.6Regulatory Bodies

      14.2.7Major Associations

      14.2.8Taxes Levied

      14.2.9Corporate Tax Structure

      14.2.10Investments

      14.2.11Major Companies

      14.3North America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.4North America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.5North America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.6North America Male Infertility Market: Country Analysis

      14.7USA Market

      14.8Summary

      14.9Market Overview

      14.9.1Country Information

      14.9.2Market Information

      14.9.3Background Information

      14.9.4Government Initiatives

      14.9.5Regulations

      14.9.6Regulatory Bodies

      14.9.7Major Associations

      14.9.8Taxes Levied

      14.9.9Corporate Tax Structure

      14.9.10Investments

      14.9.11Major Companies

      14.10USA Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.11USA Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.12USA Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.13Canada Market

      14.14Summary

      14.15Market Overview

      14.15.1Region Information

      14.15.2Market Information

      14.15.3Background Information

      14.15.4Government Initiatives

      14.15.5Regulations

      14.15.6Regulatory Bodies

      14.15.7Major Associations

      14.15.8Taxes Levied

      14.15.9Corporate Tax Structure

      14.15.10Major Companies

      14.16Canada Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.17Canada Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      14.18Canada Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15South America Market

      15.1Summary

      15.2Market Overview

      15.2.1Region Information

      15.2.2Marke Information

      15.2.3Background Information

      15.2.4Government Initiatives

      15.2.5Regulations

      15.2.6Regulatory Bodies

      15.2.7Major Associations

      15.2.8Taxes Levied

      15.2.9Corporate Tax Structure

      15.2.10Investments

      15.2.11Major Companies

      15.3South America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.4South America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.5South America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.6South America Male Infertility Market: Country Analysis

      15.7Brazil Market

      15.8Brazil Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.9Brazil Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      15.10Brazil Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16Middle East Market

      16.1Summary

      16.2Market Overview

      16.2.1Region Information

      16.2.2Market Information

      16.2.3Background Information

      16.2.4Government Initiatives

      16.2.5Regulations

      16.2.6Regulatory Bodies

      16.2.7Major Associations

      16.2.8Taxes Levied

      16.2.9Corporate Tax Structure

      16.2.10Investments

      16.2.11Major Companies

      16.3Middle East Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.4Middle East Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      16.5Middle East Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17Africa Market

      17.1Summary

      17.2Market Overview

      17.2.1Region Information

      17.2.2Market Information

      17.2.3Background Information

      17.2.4Government Initiatives

      17.2.5Regulations

      17.2.6Regulatory Bodies

      17.2.7Major Associations

      17.2.8Taxes Levied

      17.2.9Corporate Tax Structure

      17.2.10Major Companies

      17.3Africa Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.4Africa Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      17.5Africa Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)

      18Competitive Landscape And Company Profiles

      18.1Company Profiles

      18.2Bayer AG

      18.2.1Company Overview

      18.2.2Products And Services

      18.2.3Financial Overview

      18.3Merck KGaA / Merck Serono

      18.3.1Company Overview

      18.3.2Products And Services

      18.3.3Business Strategy

      18.3.4Financial Overview

      18.4Zydus Lifesciences

      18.4.1Company Overview

      18.4.2Products And Services

      18.4.3Financial Overview

      18.5Intas Pharmaceuticals Ltd

      18.5.1Company Overview

      18.5.2Products And Services

      18.5.3Financial Overview

      18.6CooperSurgical Inc.

      18.6.1Company Overview

      18.6.2Products And Services

      18.6.3Business Strategy

      18.6.4Financial Overview

      19Other Major And Innovative Companies

      19.1Vitrolife Group (Vitrolife AB)

      19.1.1Company Overview

      19.1.2Products And Services

      19.2CinnaGen Co.

      19.2.1Company Overview

      19.2.2Products And Services

      19.3Kindbody Inc.

      19.3.1Company Overview

      19.3.2Products And Services

      19.4Aytu BioScience Inc.

      19.4.1Company Overview

      19.4.2Products And Services

      19.5Fortis Healthcare Ltd.

      19.5.1Company Overview

      19.5.2Products And Services

      19.6FUJIFILM Irvine Scientific Inc.

      19.6.1Company Overview

      19.6.2Products And Services

      19.7Boston IVF

      19.7.1Company Overview

      19.7.2Products And Services

      19.8Aprilbio Co. Ltd.

      19.8.1Company Overview

      19.8.2Products And Services

      19.9Paterna Biosciences Inc.

      19.9.1Company Overview

      19.9.2Products And Services

      19.10SCSA Diagnostics Inc.

      19.10.1Company Overview

      19.10.2Products And Services

      19.11Give Legacy Inc.

      19.11.1Company Overview

      19.11.2Products And Services

      19.12ReproNovo SA

      19.12.1Company Overview

      19.12.2Products And Services

      19.13Andrology Solutions Ltd.

      19.13.1Company Overview

      19.13.2Products And Services

      19.14Inherent Biosciences Inc.

      19.14.1Company Overview

      19.14.2Products And Services

      19.15Posterity Health Inc.

      19.15.1Company Overview

      19.15.2Products And Services

      20Competitive Benchmarking

      21Competitive Dashboard

      22Key Mergers And Acquisitions

      22.1NewGenIvf Acquires Microsort Technology From GIVF To Expand Fertility Capabilities

      22.2CooperSurgical Acquires ZyMot Fertility To Strengthen ART Capabilities

      22.3Ro Acquires Dadi To Expand Digital Male Fertility Solutions

      23Recent Developments In Male Infertility

      23.1Innovative AI Technology Revolutionizes Treatment For Severe Male Infertility

      23.2Revolutionizing Male Fertility Testing With Portable, Accurate Home Diagnostics

      24Opportunities And Strategies

      24.1Global Male Infertility Market In 2029 – Countries Offering Most New Opportunities

      24.2Global Male Infertility Market In 2029 – Segments Offering Most New Opportunities

      24.3Global Male Infertility Market In 2029 – Growth Strategies

      24.3.1Market Trend Based Strategies

      24.3.2Competitor Strategies

      25Male Infertility Market, Conclusions And Recommendations

      25.1Conclusions

      25.2Recommendations

      25.2.1Product

      25.2.2Place

      25.2.3Price

      25.2.4Promotion

      25.2.5People

      26Appendix

      26.1Geographies Covered

      26.2Market Data Sources

      26.3Research Methodology

      26.4Currencies

      26.5The Business Research Company

      26.6Copyright and Disclaimer

    List Of Tables

      Table 1: Global Male Infertility Market, Historic, 2019 – 2024, $ Million
    • Table 2: Global Male Infertility Market, Forecast, 2024 – 2029, 2034F , $ Million
    • Table 3: Global Male Infertility Market TAM, 2024 And 2034, $ Million
    • Table 4: Global Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 5: Global Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 6: Global Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 7: Global Male Infertility Market, Sub-Segmentation Of Medication, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 8: Global Male Infertility Market, Sub-Segmentation Of Surgery, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 9: Global Male Infertility Market, Sub-Segmentation Of Assisted Reproductive Technology (ART), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 10: Global Male Infertility Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 11: Global Male Infertility Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 12: Asia-Pacific GDP Per Capita, By Country, 2019-2024, $
    • Table 13:  Asia-Pacific Population, By Country, 2019-2029, Millions
    • Table 14: Asia-Pacific Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 15: Asia-Pacific Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 16: Asia-Pacific Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 17: China GDP Per Capita, 2019-2024, $
    • Table 18:  China Population, 2019-2029, Millions
    • Table 19: China Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 20: China Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 21: China Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 22: India Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 23: India Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 24: India Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 25: Japan GDP Per Capita, 2019-2024, $
    • Table 26:  Japan Population, By Country, 2019-2029, Millions
    • Table 27: Japan Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 28: Japan Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 29: Japan Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 30: Australia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 31: Australia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 32: Australia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 33: Indonesia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 34: Indonesia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 35: Indonesia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 36: South Korea GDP Per Capita, 2019-2024, $
    • Table 37:  South Korea Population, 2019-2029, Millions
    • Table 38: South Korea Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 39: South Korea Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 40: South Korea Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 41: Western Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 42:  Western Europe Population, By Country, 2019-2029, Millions
    • Table 43: Western Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 44: Western Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 45: Western Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 46: UK Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 47: UK Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 48: UK Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 49: Germany Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 50: Germany Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 51: Germany Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 52: France Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 53: France Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 54: France Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 55: Italy Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 56: Italy Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 57: Italy Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 58: Spain Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 59: Spain Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 60: Spain Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 61: Eastern Europe GDP Per Capita, By Country, 2019-2024, $
    • Table 62:  Eastern Europe Population, By Country, 2019-2029, Millions
    • Table 63: Eastern Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 64: Eastern Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 65: Eastern Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 66: Russia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 67: Russia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 68: Russia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 69: North America GDP Per Capita, By Country, 2019-2024, $
    • Table 70:  North America Population, By Country, 2019-2029, Millions
    • Table 71: North America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 72: North America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 73: North America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 74: USA GDP Per Capita, 2019-2024, $
    • Table 75:  USA Population, 2019-2029, Millions
    • Table 76: USA Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 77: USA Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 78: USA Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 79: Canada GDP Per Capita, 2019-2024, $
    • Table 80:  Canada Population, By Country, 2019-2029, Millions
    • Table 81: Canada Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 82: Canada Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 83: Canada Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 84: South America GDP Per Capita, By Country, 2019-2024, $
    • Table 85:  South America Population, By Country, 2019-2029, Millions
    • Table 86: South America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 87: South America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 88: South America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 89: Brazil Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 90: Brazil Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 91: Brazil Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 92: Middle East GDP Per Capita, By Country, 2019-2024, $
    • Table 93:  Middle East Population, By Country, 2019-2029, Millions
    • Table 94: Middle East Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 95: Middle East Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 96: Middle East Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 97: Africa GDP Per Capita, By Country, 2019-2024, $
    • Table 98:  Africa Population, By Country, 2019-2029, Millions
    • Table 99: Africa Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 100: Africa Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 101: Africa Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Table 102: Global Male Infertility Market, Key Competitor Estimated Market Shares, 2024, Percentage (%)
    • Table 103: Bayer AG – Financial Overview, 2020 – 2024, $Billion
    • Table 104: Merck KGaA / Merck Serono – Financial Overview, 2020 – 2024, $Billion
    • Table 105: Zydus Lifesciences – Financial Overview, 2020 – 2024, $Billion
    • Table 106: Intas Pharmaceuticals Ltd – Financial Overview, 2024, $Billion
    • Table 107: CooperSurgical Inc – Financial Overview, 2020 – 2024, $Billion
    • Table 108: Male Infertility Market, Competitive Benchmarking (In USD Millions)
    • Table 109: Male Infertility Equipment Market, Competitive Dashboard
    • Table 110: Global Male Infertility Market Size Gain ($ Million), 2024 – 2029, By Country
    • Table 111: Global Male Infertility Market Size Gain ($ Million), Segmentation By Product Type, 2024 – 2029
    • Table 112: Global Male Infertility Market Size Gain ($ Million), Segmentation By Test Type, 2024 – 2029
    • Table 113: Global Male Infertility Market Size Gain ($ Million), Segmentation By End-User, 2024 – 2029
    • Table 114: Male Infertility Market Data Sources

    List Of Figures

      Figure 1: Global Male Infertility Market Segmentation By Treatment Type
    • Figure 2: Global Male Infertility Market Segmentation By Test Type
    • Figure 3: Global Male Infertility Market Segmentation By End-User
    • Figure 4: Global Male Infertility Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
    • Figure 5: Global Male Infertility Market, Historic, 2019 – 2024, $ Million
    • Figure 6: Global Male Infertility Market, Forecast, 2024 – 2029, 2034F, $ Million
    • Figure 7: Global Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 8: Global Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 9: Global Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 10: Global Male Infertility Market, Sub-Segmentation Of Medication, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 11: Global Male Infertility Market, Sub-Segmentation Of Surgery, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 12: Global Male Infertility Market, Sub-Segmentation Of Assisted Reproductive Technology (ART), By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 13: Global Male Infertility Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 14: Global Male Infertility Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 15: Asia-Pacific Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 16: Asia-Pacific Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 17: Asia-Pacific Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 18: China Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 19: China Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 20: China Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 21: India Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 22: India Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 23: India Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 24: Japan Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 25: Japan Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 26: Japan Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 27: Australia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 28: Australia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 29: Australia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 30: Indonesia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 31: Indonesia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 32: Indonesia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 33: South Korea Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 34: South Korea Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 35: South Korea Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 36: Western Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 37: Western Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 38: Western Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 39: UK Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 40: UK Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 41: UK Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 42: Germany Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 43: Germany Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 44: Germany Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 45: France Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 46: France Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 47: France Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 48: Italy Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 49: Italy Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 50: Italy Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 51: Spain Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 52: Spain Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 53: Spain Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 54: Eastern Europe Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 55: Eastern Europe Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 56: Eastern Europe Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 57: Russia Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 58: Russia Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 59: Russia Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 60: North America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 61: North America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 62: North America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 63: USA Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 64: USA Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 65: USA Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 66: Canada Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 67: Canada Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 68: Canada Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 69: South America Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 70: South America Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 71: South America Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 72: Brazil Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 73: Brazil Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 74: Brazil Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 75: Middle East Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 76: Middle East Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 77: Middle East Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 78: Africa Male Infertility Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 79: Africa Male Infertility Market, Segmentation By Test Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 80: Africa Male Infertility Market, Segmentation By End-User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, $ Million
    • Figure 81: Global Male Infertility, Key Competitor Estimated Market Shares, 2024, Percentage (%)
    • Figure 82: Bayer AG – Financial Overview, 2020 – 2024, $ Billion
    • Figure 83: Merck KGaA / Merck Serono – Financial Overview, 2020 – 2024, $ Billion
    • Figure 84: Zydus Lifesciences – Financial Overview, 2020 – 2024, $ Billion
    • Figure 85: CooperSurgical Inc – Financial Overview, 2020 – 2024, $ Billion
    • Figure 86: Geographic Regions Covered

    Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

    Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

    2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

    Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

    Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

    Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

    Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

    Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

    CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

    Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

    Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

    Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

    2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

    Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

    Future Demand and Leading Companies Shaping the Common Cold Market to 2029

    Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

    Value Based Care Payment Market 2023 – By Model (Accountable Care Organization (ACO), Bundled Payments, Patient-Centered Medical Home (PCMH), Pay For Performance (P4P)), By Deployment Type (Cloud Based, On-Premise), By E...

    Fertility Services Market 2023 – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embryo Banking, Fresh Donor,...

    IVF Services Market Report 2026 - Global Outlook – By Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), Donor Egg IVF Cycles ), By Service Provider (Fertility Clinics, Hospitals), By End User (Infe...

    Prenatal Testing & Newborn Screening Market Report 2026 - Global Outlook – By Diagnostic Type (Non-Invasive, Invasive ), By Technology (Screening Technology, Diagnostic Technology ), By End User (Hospitals, Diagnostic ce...

    Payer Services Market Report 2026 - Global Outlook – By Outsourcing Services (Business Process Outsourcing Services, Knowledge Process Outsourcing Services, Information Technology Outsourcing Services), By Application (R...

    Fertility Services Market Report 2026 - Global Outlook – By Procedure (Assisted Reproductive Technology (Art), In-Vitro Fertilization, Artificial Insemination), By Service (Fresh Non-Donor, Frozen Non-Donor, Egg And Embr...

    Revenue Cycle Management Software Market Report 2026 - Global Outlook – By Product (Integrated, Standalone ), By Function (Claim And Denial, Medical Biling And Coding, Patient Insurance Eligibility Check, Payment Remitta...

    Robotic Surgery Services Market Report 2026 - Global Outlook – By Component (Systems, Accessories, Services), By Application (General Surgery, Urological Surgery, Gynecological Surgery, Orthopaedics Surgery, Neurosurgery...

    Back to top